Documente Academic
Documente Profesional
Documente Cultură
I. Categorize patients
CATEGORY STATUS OF ANIMAL ACTION PLAN
I. Touching, feeding, licking of Healthy, unknown, LOCAL WOUND CARE
healthy skin with no open wound, escaped ,
no mucous membrane contact sick, proven rabid Consider exposure prophylaxis if likely
Key: RELIABLE HISTORY to be re-exposed
II. Superficial scratch/ abrasion Healthy Vaccine
without bleeding, nibbling of Observe 10-14 days
uncovered skin; hematoma only; If animal remains healthy. Discontinue
licks on broken skin or healing vaccination or continue as pre-exposure
wounds; Category I but unreliable prophylaxis
history
Unknown, escaped,
sick, proven rabid
III. Single /multiple transdermal Healthy Rabies Ig + Vaccie
bites; licking of mucous Observe 10 to 14 days
membrane; ALL head and neck
exposure; EXPOSURE to rabid If animal remains healthy, Discontinue
patients (bites, contamination of vaccination or continue as pre-exposure
mucous membranes with saliva/ prophylaxis
fluids (through splattering, mouth
to mouth res, licks of eyes, lips, If animal gets sick or dies, do lab exam
vulva)); handling of infected of animal head
carcass or ingestion or raw (+) continue vaccination
infected meat (-) may discontinue vaccination
orcontinue
IV.Initiate treatment
• POST-EXPOSURE TREATMENT
• PRINCIPLES:
Minimize the amount of virus at the site of inoculation develop a high titer of neutralizing
antibodies EARLY
COMPONENTS:
Passive Immunization
Human
rabies
immune Imogam 300 iu/ 2ml vial 20 units/kg No skin test needed
globulin
(HRIG)
Now available:
Fragments of Equine Antirabies Immune globulin (FAVIRAB)
ACTIVE IMMUNIZATION
0.1ml
8-site ID* - 0.1 ml 8 0 4 0 0 1 1
**
2-1-1 IM 0.5 ml 1.0 ml 1.0 ml 2 0 1 0 1 0 0
* 2 injections each over the deltoid, lateral thigh, suprascapular area and lower quadrant of the abdomen
on day 0 and over the deltoid and thigh on day 7
** 8- site ID regimen with PVRV used only in RITM
SITES
NEVER GIVE IN THE GLUTEAL AREA
Intradermal:
• If no satisfactory papule results, repeat on opposite side
• Requires skilled health worker
• In health facilities seeing more animal bite cases
SUPPORTIVE MANAGEMENT
1. LOCAL WOUND CARE – the cornerstone of rabies prevention; reduces risk of 90%
• VIGOROUS washing with soap and water
• Irrigate with virucidal agents like povidone iodine
2. DELAY WOUND SUTURING – after RIG infiltrated into the wound
3. AVOID creams, ointments or occlusive dressing
4. ANTIBIOTIC PROPHYLAXIS
• >50% of cat bites and 15% to 20% of dog bites become secondarily infected
• Give to all category III cat and dog bites
• NO obvious infection: Amoxicillin
• Frankly infected: Cloxacillin or Co-amoxyxlavulanic acid
5. CONSIDER ANTI-TETEANUS PROPHYLAXIS – all anima bite wounds are considered tetanus-prone
Table 2. Guide to Tetanus Prophylaxis in Routine Wound Management
Non-immune Immune**
Type of Injury
Incomplete Booster >10 yr Booster <10 yr
Tetanus prone DT/DPT +TIG* Tetanus Toxoid >5 yrs since booster give Tetanus Toxoid; <5 yrs
NONE
b.THERAPY
• MORTALITY rate is almost 100%
• Rabies is better prevented than treated
• No specific chemotherapy for clinical rabies
• Supportive care: IV fluids, sedation with midazolam or diazepam
c.PRECAUTIONS
• Immediate isolation of suspected and confirmed cases. Rabies is communicable.
• Restrain patient
• Healthcare givers in direct contact with patient should be equipped with goggles, face mask,
gowns, gloves
• Pay special attention to patient’s saliva, sputum, CSF, and other body secretions. Dispose of
equipment or instruments which may harbour rabies virus properly -> disinfect
• Sterilize equipment: 60ᵒC, at least 30 minutes
• HANDWASHING
PRE-EXPOSURE PROPHYLAXIS
Indications:
1.Individuals at high risk for rabies: veterinarians, animas handlers, laboratory workers
2.Hospital staff involved in management of rabies patients
Regimens: day 0, 3, 28
• IM - PVRV 0.5ml or PDEV 1.0ml or PCECV 1.0ml
• ID – PVRV 0.1 ml or PDEV 0.2ml or PCECV 0.2ml
• Booster: every 1 to 3 years